Avantor Inc.

Avantor, Inc. is a provider of mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Avantor, Inc. engages in providing mission critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies and applied materials industries. It sells materials, equipment, instrumentation, and offers specialty procurement. The firm operates through the following segments: the Americas, Europe, and AMEA. The company was founded by John Townsend Baker in 1904 and is headquartered in Radnor, PA.

RADNOR, Pa. , Nov. 30, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries received a score of 100 on the Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index (CEI) and was recognized as an Equality 100 Award: Leader in LGBTQ+ Workplace Inclusion honoree.

Avantor® Receives Top Score on Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index

RADNOR, Pa. , Nov. 22, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that the company will host an Investor Day on December 8, 2023, at 9:00 a.m.

Avantor® to Host Investor Day on December 8, 2023

RADNOR, Pa. , Nov. 16, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, announced that President and CEO Michael Stubblefield, will be participating in a fireside chat at the Evercore ISI HealthCONx Conference in Miami, Florida on Tuesday, November 28, at 10:00 a.m.

Avantor® to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Avantor's (AVTR) latest offerings are likely to provide its customers with products, materials and services that would aid in accelerating therapeutics.

Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft third-quarter performance.

Avantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top

Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Avantor, Inc. (AVTR) Q3 Earnings: A Look at Key Metrics

Avantor, Inc. (NYSE:AVTR ) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President & CEO Brent Jones - EVP & CFO Conference Call Participants Daniel Brennan - TD Cowen Vijay Kumar - Evercore ISI Jack Meehan - Nephron Research Michael Ryskin - Bank of America Patrick Donnelly - Citi Rachel Vatnsdal - JPMorgan Luke Sergott - Barclays Daniel Leonard - UBS Catherine Schulte - Robert W. Baird Operator Good morning.

Avantor, Inc. (AVTR) Q3 2023 Earnings Call Transcript

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.25 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.34 per share a year ago.

Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates

Net sales of $1.72 billion, decrease of 7.3%; core organic decline of 7.9% Net income of $108.4 million; Adjusted EBITDA of $317.8 million Diluted GAAP EPS of $0.16; adjusted EPS of $0.25 Operating cash flow of $230.7 million; free cash flow of $193.0 million Adjusted net leverage of 3.9X; repaid more than $650 million of debt year to date RADNOR, Pa. , Oct. 27, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, today reported financial results for the third quarter ended September 30, 2023.

Avantor® Reports Third Quarter 2023 Results

Catalent

Danaher

DexCom

Inspire Medical Systems Inc

Coca-Cola

Eli Lilly

Novo Nordisk

PepsiCo

Insulet

Repligen

Thermo Fisher Scientific

Walmart

Citing Vanda Research, the Wall Street Journal reports that the average individual-investor stock portfolio is up 150% since the start of 2014, versus around 140% for the S&P 500's SPX during the same period.

The weight-loss drugs are coming for these companies — but here's why Coke, others, may be spared, says JPMorgan

Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for

RADNOR, Pa. , Sept. 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, will release its third quarter 2023 financial results before the market opens on Friday, October 27, and will hold a conference call on the same day at 8:00 a.m.

Avantor® to Host Third Quarter 2023 Earnings Call on Friday, October 27, 2023

RADNOR, Pa. , Sept. 26, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and technology industries, today announced that Benoit Gourdier will join the company as EVP, Biopharma Production on October 2, 2023.

Avantor® Announces Ger Brophy to Retire in 2024; Benoit Gourdier Appointed EVP, Biopharma Production

Board Will Accelerate Solutions for Life Sciences Customers; Includes Experts in Biologic Manufacturing Sciences and Technology, Chemistry and Gene Therapy RADNOR, Pa. , Sept. 21, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services for customers in the life sciences and technology industries, today announced the creation of a new Scientific Advisory Board (SAB), which will provide strategic guidance and consult on the Company's mid- to long-term research and development efforts to deliver solutions for the life sciences industry, including biotech and pharma customers.

Avantor® Announces New Scientific Advisory Board

Avantor's (AVTR) partnership is likely to meet the growing need among biopharma and life science companies for end-to-end solutions.

Avantor's (AVTR) Tie-Up to Address Temperature-Specific Logistics

Capri Holdings Ltd

Bio-Techne

AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.

New Strong Sell Stocks for September 11th

Partnership will satisfy growing need among biopharma and life science companies for end-to-end solutions so customers can focus on science RADNOR, Pa., Sept. 7, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, has entered into an agreement with Tobin Scientific, a leading provider of biopharma cold chain, ambient storage, and transport & logistics services, to support end-to-end moves for biopharma customers looking to relocate their labs, research facilities, and samples.

Avantor® Partners with Tobin Scientific to Provide End-to-End Solution for Research Lab Relocations, Sample Transport, and GMP Storage Services

RADNOR, Pa. , Aug. 29, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, announced that Michael Stubblefield, President and CEO, will be participating in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference in New York on Tuesday, September 12, at approximately 8:10 a.m.

Avantor® to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Berkshire Hills Bancorp

AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.

New Strong Sell Stocks for August 22nd

Despite Avantor's (AVTR) strength in end markets, it reports an overall soft second-quarter performance.

Avantor (AVTR) Q2 Earnings Lag Estimates, FY23 View Revised

Avantor, Inc. (NYSE:AVTR ) Q2 2023 Earnings Conference Call July 28, 2023 8:00 AM ET Company Participants Christina Jones - Vice President, Investor Relations Michael Stubblefield - President & Chief Executive Officer Tom Szlosek - Executive Vice President & Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley Michael Ryskin - Bank of America Luke Sergott - Barclays Vijay Kumar - Evercore ISI Rachel Vatnsdal - JPMorgan Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Justin Bowers - Deutsche Bank Operator Good morning. My name is Emily and I'll be your conference operator today.

Avantor, Inc. (AVTR) Q2 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Avantor, Inc. (AVTR) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Here's What Key Metrics Tell Us About Avantor, Inc. (AVTR) Q2 Earnings

Shares of Avantor Inc. AVTR, -2.14% fell 4% premarket on Friday after the company, a provider of lab equipment and services for the biopharma, healthcare and other industries, reported second quarter earnings below analysts' estimates. Market trends, particularly in biopharma, “were more challenging than anticipated” during the quarter, CEO Michael Stubblefield said in a statement.

Avantor shares fall after ‘challenging' biopharma market hurts second quarter results

Avantor, Inc. (AVTR) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.37 per share a year ago.

Avantor, Inc. (AVTR) Misses Q2 Earnings and Revenue Estimates

Net sales of $1.74 billion, decrease of 8.7%; core organic decline of 6.5% Net income of ($7.3) million; Adjusted EBITDA of $343.0 million Diluted GAAP EPS of ($0.01); adjusted EPS of $0.28 Operating cash flow of $168.2 million; free cash flow of $138.1 million Adjusted net leverage of 3.9X RADNOR, Pa. , July 28, 2023 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, education and government, advanced technologies and applied materials industries, today reported financial results for the second quarter ended June 30, 2023.

News for Avantor Inc. Stock (AVTR)